Small Molecules
Candidate Drug/Lead Compound
Indication
Lead Optimization
IND Enabling
IND Filed
Phase I
Phase II
Phase III

Umifenovir
(Licensed)

COVID-19

S-007-867

Thrombosis

S-007-1500
(Licensed)

Fracture healing

L-Ormeloxifene
(Licensed)

Female contraceptive

S-011-1793

Malaria

S-016-1348

Cancer (Smac mimetic)

SB-CDRI4-105

Neuropathic pain

GS/IICT 5/6

Anti-angiogenic

S-016-1271

Complicated UTI
Phytopharmaceuticals
Phytolead
Indication
Lead Optimization
IND Enabling
IND Filed
Phase I
Phase II
Phase III

Picroliv

Non-alcoholic fatty liver disease

NMITLI -118 AF1

Stroke

Chebulinic Acid Enriched Fraction
(Licensed)

Benign Prostatic Hyperplasia

1703F003 4-HIL

Polycystic Ovary Syndrome
Novel Formulations
Formulation
API
Indication
Lead Optimization
Subsequent New Drug Application
Phase I
Phase II
Phase III

Centinhale
(Dry powder formulation)

Rifabutin and Isoniazid

MDR TB

Amphotericin formulation
(Ophthalmic formulation)
(Licensed)

Amphotericin

Fungal keratitis

Facebook
Instagram
Twitter
linked-In
YouTube
WhatsApp